Correlation Between Pfizer and SPDR Morgan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and SPDR Morgan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and SPDR Morgan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and SPDR Morgan Stanley, you can compare the effects of market volatilities on Pfizer and SPDR Morgan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of SPDR Morgan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and SPDR Morgan.

Diversification Opportunities for Pfizer and SPDR Morgan

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and SPDR is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and SPDR Morgan Stanley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPDR Morgan Stanley and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with SPDR Morgan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPDR Morgan Stanley has no effect on the direction of Pfizer i.e., Pfizer and SPDR Morgan go up and down completely randomly.

Pair Corralation between Pfizer and SPDR Morgan

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the SPDR Morgan. In addition to that, Pfizer is 1.11 times more volatile than SPDR Morgan Stanley. It trades about -0.02 of its total potential returns per unit of risk. SPDR Morgan Stanley is currently generating about 0.09 per unit of volatility. If you would invest  15,382  in SPDR Morgan Stanley on August 26, 2024 and sell it today you would earn a total of  5,114  from holding SPDR Morgan Stanley or generate 33.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  SPDR Morgan Stanley

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
SPDR Morgan Stanley 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SPDR Morgan Stanley are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, SPDR Morgan may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pfizer and SPDR Morgan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and SPDR Morgan

The main advantage of trading using opposite Pfizer and SPDR Morgan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, SPDR Morgan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SPDR Morgan will offset losses from the drop in SPDR Morgan's long position.
The idea behind Pfizer Inc and SPDR Morgan Stanley pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules